FAU team develops new method to forecast Covid-19 trial outcome
A research team at Florida Atlantic University (FAU)’s College of Engineering and Computer Science in the US has created a new technique to predict if…
Patent Analytics
Trends in IP Protection— Clinical Trials Arena (Last 20 Years)
Heavy IP Protected Regions — Clinical Trials Arena (Last 20 Years)
Top Players Protecting their IP — Clinical Trials Arena (Last 20 Years)
Top Themes Protected by IP - Clinical Trials Arena (Last 20 Years)
All markets data shared in the dashboard is copyright of GlobalData PLC and is subject to the GlobalData Terms & Conditions. Content in the dashboard should not be viewed as a recommendation and should not be relied upon to make investment decisions. We make every effort to ensure our content is accurate and to correct mistakes as soon as possible. If you spot an error please email editorialenquiries@globaldata.com. Further information about our editorial standards and complaints procedure is available here. GlobalData is not responsible for the use of any content outside the scope of the GlobalData Terms & Conditions.
Latest News
View More
FDA places clinical hold on Magenta’s Phase I/II leukaemia trial
The US Food and Drug Administration (FDA) has issued a clinical hold letter for Magenta Therapeutics’ investigational new drug application to conduct a Phase I/II…
Oravax to commence trials of oral Covid-19 vaccine in Israel
Oramed Pharmaceuticals’s Oravax is set to initiate clinical trials of its oral Covid-19 vaccine in Israel with the study protocol…
India may deploy Covid-19 vaccine boosters: Brazil, South Africa unlikely to follow soon
Need to know: Vaccine manufacturing scale-up and reduced exports opens possibility India may deploy boosters as soon as August Boosters…
UCLH commences trial of new Alzheimer’s drug candidate
The University College London Hospitals (UCLH) in the UK has initiated a clinical trial of a new drug candidate, E2814,…
Takeda reports data from Phase III von Willebrand disease trial
Takeda Pharmaceutical has reported positive data from Phase III clinical trial assessing recombinant von Willebrand factor (rVWF) prophylaxis for von…
Company A-Z
View More
GlobalData
GlobalData exists to help businesses decode the future to profit from faster, more informed decisions.
